NJ State Employees Deferred Compensation Plan’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-560
| Closed | -$4.34K | – | 440 |
|
|
2025
Q1 | $4.34K | Hold |
560
| – | – | ﹤0.01% | 444 |
|
|
2024
Q4 | $7.41K | Hold |
560
| – | – | ﹤0.01% | 461 |
|
|
2024
Q3 | $5.59K | Hold |
560
| – | – | ﹤0.01% | 474 |
|
|
2024
Q2 | $12.5K | Hold |
560
| – | – | ﹤0.01% | 472 |
|
|
2024
Q1 | $32.9K | Hold |
560
| – | – | ﹤0.01% | 472 |
|
|
2023
Q4 | $12.4K | Hold |
560
| – | – | ﹤0.01% | 482 |
|
|
2023
Q3 | $12.1K | Hold |
560
| – | – | ﹤0.01% | 481 |
|
|
2023
Q2 | $37.8K | Sell |
560
-40
| -7% | -$16.5K | 0.01% | 480 |
|
|
2023
Q1 | $280K | Hold |
600
| – | – | 0.04% | 383 |
|
|
2022
Q4 | $240K | Hold |
600
| – | – | 0.04% | 397 |
|
|
2022
Q3 | $195K | Hold |
600
| – | – | 0.03% | 420 |
|
|
2022
Q2 | $159K | Hold |
600
| – | – | 0.03% | 436 |
|
|
2022
Q1 | $180K | Hold |
600
| – | – | 0.02% | 466 |
|
|
2021
Q4 | $211K | Hold |
600
| – | – | 0.03% | 462 |
|
|
2021
Q3 | $153K | Hold |
600
| – | – | 0.02% | 483 |
|
|
2021
Q2 | $400K | Hold |
600
| – | – | 0.05% | 350 |
|
|
2021
Q1 | $521K | Buy |
600
+240
| +67% | +$256K | 0.07% | 287 |
|
|
2020
Q4 | $334K | Hold |
360
| – | – | 0.05% | 352 |
|
|
2020
Q3 | $370K | Hold |
360
| – | – | 0.07% | 275 |
|
|
2020
Q2 | $365K | Hold |
360
| – | – | 0.07% | 282 |
|
|
2020
Q1 | $313K | Hold |
360
| – | – | 0.07% | 273 |
|
|
2019
Q4 | $386K | Hold |
360
| – | – | 0.07% | 337 |
|
|
2019
Q3 | $333K | Buy |
360
+120
| +50% | +$132K | 0.06% | 358 |
|
|
2019
Q2 | $271K | Hold |
240
| – | – | 0.05% | 453 |
|
|
2019
Q1 | $326K | Buy |
240
+40
| +20% | +$54.2K | 0.06% | 407 |
|
|
2018
Q4 | $231K | Buy |
+200
| New | +$225K | 0.05% | 438 |
|
|
2017
Q4 | – | Sell |
-160
| Closed | -$215K | – | 470 |
|
|
2017
Q3 | $215K | Sell |
160
-414
| -72% | -$436K | 0.04% | 431 |
|
|
2017
Q2 | $464K | Hold |
574
| – | – | 0.09% | 295 |
|
|
2017
Q1 | $354K | Hold |
574
| – | – | 0.07% | 312 |
|
|
2016
Q4 | $307K | Hold |
574
| – | – | 0.06% | 310 |
|
|
2016
Q3 | $297K | Hold |
574
| – | – | 0.06% | 311 |
|
|
2016
Q2 | $236K | Hold |
574
| – | – | 0.05% | 332 |
|
|
2016
Q1 | $318K | Hold |
574
| – | – | 0.07% | 305 |
|
|
2015
Q4 | $437K | Hold |
574
| – | – | 0.09% | 291 |
|
|
2015
Q3 | $315K | Buy |
+574
| New | +$348K | 0.07% | 314 |
|
Other funds holding KYNB
AC
CCM
NJ State Employees Deferred Compensation Plan's KYNB Position: Q2 2025 in Review
NJ State Employees Deferred Compensation Plan sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 560 shares — an estimated $4.34K sold.
NJ State Employees Deferred Compensation Plan first reported a position in KYNB in Q3 2015 and held it in 35 quarters. The position peaked at $521K in Q1 2021. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.
- NJ State Employees Deferred Compensation Plan reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
- NJ State Employees Deferred Compensation Plan sold 560 Kyntra Bio shares in Q2 2025, an estimated $4.34K.
- NJ State Employees Deferred Compensation Plan first reported a position in Kyntra Bio in Q3 2015 and held it in 35 quarters.
- NJ State Employees Deferred Compensation Plan's Kyntra Bio position peaked at $521K in Q1 2021.
- 30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2025, filed 5 Aug 2025.